Ravinder K. Grewal

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

31h-index4.8kcitations168works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(87), Medical Imaging Techniques and Applications(16), Radiopharmaceutical Chemistry and Applications(12), Neuroendocrine Tumor Research Advances(10), Radiomics and Machine Learning in Medical Imaging(10)

Publications168 total

Table S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S6 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S5 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Table S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
Figure S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2025Open Access
99mTc-MAA Scintigraphy for Assessing Hepatic Arterial Infusion Pump: The Rate Being a Snare
World Journal of Nuclear Medicine·2025Open Access
Effect of Dietary Cation-anion Difference (DCAD) on Dry Matter Intake, Milk Yield and Reproductive Health of Transition Cattle and Buffalo: A Comprehensive Review
Asian Journal of Advances in Agricultural Research·2025Open Access
[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer
EJNMMI Research·2024Open Access
398P Magnetic resonance imaging detects bone alterations in corticosteroid treated boys with DMD
Neuromuscular Disorders·2024
1931P Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC)
Annals of Oncology·2024· 1 citedOpen Access
Focal: A Proposed Method of Leveraging LLMs for Automating Assessments
International Conference on Computers in Education·2023Open Access
Abstract PO-072: Durvalumab in combination with radioactive iodine in recurrent/metastatic thyroid cancers: Update on clinical and correlative analyses
Clinical Cancer Research·2023
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
European Journal of Nuclear Medicine and Molecular Imaging·2023· 6 citedOpen Access
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
European Journal of Nuclear Medicine and Molecular Imaging·2023· 7 citedOpen Access
Figure S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
2023Open Access
page 1 of 9Next →

Frequent Co-authors

R. Michael Tuttle(20), Steven M. Larson(19), Heiko Schöder(9), Mona M. Sabra(8), Andrew D. Zelenetz(6), Alan L. Ho(5), Ronald Ghossein(5), H. William Strausś(5), Alison J. Moskowitz(5), Paul A. Hamlin(5), Steven M. Horwitz(5), Matthew J. Matasar(5), Ariela Noy(5), Somali Gavane(4), James A. Fagin(4), Mithat Gönen(4), John F. Gerecitano(4), Anita Kumar(4), Craig S. Sauter(4), Anas Younes(4)